Growth Hormone and/or Rosiglitazone for HIV-Associated Increased Abdominal Fat and Insulin Resistance

Clinical trial NCT00130286 · COMPLETED

Trial details

NCT number: NCT00130286
Sponsor: Weill Medical College of Cornell University
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

HIV-Associated Lipodystrophy Syndrome Insulin Resistance HIV Infections Metabolic Syndrome X Body Weight Changes

Start date: 2005-03-01
Primary completion: 2010-08-01
Enrollment: 77

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.